John Gordon Freund, Director at Protara Therapeutics, holds 129.73K shares in SI-Bone (Ticker: SIBN), holds 88.19K shares in Collegium Pharmaceutical (Ticker: COLL), holds 56.33K shares in Sutro Biopharma (Ticker: STRO). Most recently, John Gordon Freund Sold ― shares of SI-Bone on Aug 11, 2023 for an estimated value of 615.90K.
What is the percentage of profitable transactions made by John Gordon Freund?
The percentage of profitable transactions made by John Gordon Freund is 60%.
What is the average return per transaction made by John Gordon Freund?
The average return per transaction made by John Gordon Freund is 11.50%.
What stocks does John Gordon Freund hold?
John Gordon Freund holds: TARA, STRO, SIBN, XNPT, TTPH, COLL, CNCE, HNSN, MAKO, ~MAPP stocks.
What was John Gordon Freund’s latest transaction?
John Gordon Freund latest transaction was an Informative Sell of $615.90K.
What was John Gordon Freund's most profitable transaction?
John Gordon Freund’s most profitable transaction was an Informative Buy of TARA stock on November 12, 2019. The return on the trade was 90.90%.
What is John Gordon Freund's role in Protara Therapeutics?
John Gordon Freund's role in Protara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.